EpiEndo and AlveoliX achieve milestone in ulcerative colitis treatment
Collaboration yields promising Barriolide therapy Enterothelin
Read More
Tag: EpiEndo
EpiEndo successfully completes phase 1 study into respiratory treatment
Orally available EP395 has met all endpoints in safety and is now undergoing phase 2 planning
Read More
- RougeTx launches with $58 million series A financing for HHT therapy
- Lundbeck presents phase 1b data for Lu AF28996 in advanced Parkinson’s disease
- Bespak and SNBL agree global access deal for FDA‑approved nasal device
- NEMLUVIO data show sustained three‑year responses in atopic dermatitis
- SMC accepts AQUIPTA for eligible migraine patients in Scotland
